Skip to content
Screener

Bio-Techne Corp. TECH Q4 2026 Annual earnings

Reported August 12, 2026 · Before market open

Revenue$321.2MBeat by $6.6M
EPS$0.52Beat by $0.00
Revenue estimate$314.6M
EPS estimate$0.52
“Bio-Techne ended fiscal 2026 with improved performance and solid execution across the business, reflecting the value our differentiated solutions bring across biopharma, research and diagnostic workflows. We continue to make progress toward completing Bio-Techne's acquisition by Merck KGaA, Darmstadt, Germany, and look forward to the opportunities this transaction is expected to create for our customers and employees.”
Kim Kelderman

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$292.4M
EPS estimate$0.46

Financials

Q4 2026

Income statement

See full
Revenue$321.2M+1.3%
Gross profit$211.4M+6.3%
Operating income$74.3M—
Net income$54.6M—
EPS (diluted)$0.35—

Balance sheet

See full
Cash & equivalents$264.7M+63.2%
Total debt$289.1M-34.9%
Total equity$2.1B+9.9%
Total assets$2.6B+1.1%

Cash flow

See full
Operating cash flow$95.4M-2.8%
CapEx$8.5M+73.4%
Free cash flow$86.9M-6.8%

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$11.34B+41.5%
Enterprise value$11.37B+37.0%
P/E62.4×—
P/S9.3×+2.8×

Profitability

See full
Gross margin65.8%+1.0pp
Operating margin20.7%—
Net margin15%—
FCF margin21.7%+0.6pp

Returns & leverage

See full
Return on equity9%—
Debt / equity0.1×-0.1×
Current ratio4.5×+1.1×

Segments

By product

See full
Consumables$260.7M+3.1%
Instruments$31.5M+9.1%
Service$23.1M-22.1%
Royalty$5.9M+6.5%

By segment

See full
Protein Sciences$231.2M+2.1%
Diagnostics And Spatial Biology$90.1M+0.5%

FAQ

When did Bio-Techne Corp. report Q4 2026 earnings?
Bio-Techne Corp. (TECH) reported Q4 2026 earnings on August 12, 2026 before market open.
What were Bio-Techne Corp.'s Q4 2026 revenue and EPS?
Bio-Techne Corp. reported revenue of $321.2M and eps of $0.52 for Q4 2026.
Did Bio-Techne Corp. beat estimates in Q4 2026?
Revenue beat the consensus estimate of $314.6M by $6.6M. EPS beat the consensus estimate of $0.52 by $0.00.
How did Bio-Techne Corp.'s Q4 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 1.3% from $317.0M a year earlier and eps declined 1.9% from $0.53.
Where can I find Bio-Techne Corp.'s Q4 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-094391) and the 10-K periodic report (0001104659-26-100322) directly on SEC EDGAR. The filing index links above go to sec.gov.